APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Portfolio Pulse from
The Schall Law Firm has announced a class action lawsuit against Applied Therapeutics, Inc. for alleged securities fraud. Investors who purchased APLT securities between January 3, 2024, and December 2, 2024, are encouraged to join the lawsuit.
January 06, 2025 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Applied Therapeutics, Inc. is facing a class action lawsuit for alleged securities fraud, which could negatively impact its stock price in the short term.
The announcement of a class action lawsuit for securities fraud is likely to create negative sentiment among investors, potentially leading to a decline in APLT's stock price. Legal issues of this nature can affect investor confidence and result in increased volatility.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100